Skip to main content

Table 1 Main laboratory data and characteristics of the studied population

From: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

  Diagnosis
  CHC n 36 FL n 45 NASH n 42
  Gender Mean SD Gender Mean SD Gender Mean SD
Age   44.5 10.0   42.3 9.1   40.4 10.5
TGF-β1 ng/mL*   87.5 39.5   129.1 45.4   116.8 42.2
CRP      0.8 0.4   0.9 0.4
ALT U/L#   72.7 25.6   49.2 17.8   54.3 21.8
Ferritin ng/mL 17 F 203.6 86.5 21 F 232.3 117.4 19 F 279.8 150.3
Ferritin ng/mL 19 M 396.4 153.5 24 M 381.5 137.2 23 M 357.2 132.3
Waist Circumference (cm)     21 F 98 6.1 19 F 100 4.7
Waist Circumference (cm)     24 M 105 6.3 23 M 108 7.7
HOMA      3.2 1.4   3.4 1.5
   Median Range   Median Range   Median Range
BMI  26 22–30   29 27–32   29 27–32
Fibrosis score   1 1–3      1 1–2
US steatosis Score   2 1–3      1 1–3
  1. CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; HOMA, homeostasis model assessment-insulin resistance index.
  2. * P < 0.001, FL versus CHC and 0.008, NASH versus CHC patients; # P < 0.001, CHC versus FL and NASH patients; ‡ P < 0.001, CHC versus FL and NASH patients.